Review Session Flashcards

1
Q

In the presence of oxygen, what post‐translational modifications would be found on HIF1a?

A

Hydroxyl group + ubiquitination

Hypoxia and the oxygen effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does prolyl hydroxylase enzymes (PHDs) do?

A

When oxygen is present, PHD adds a hydroxyl group (OH) to HIF1a
(post-translational modification)

Hypoxia and the oxygen effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does pVHL complex do?

A

pVHL ubiquitinylates the hydroxylated HIFa. This has two effects:
1. Prevents it to bind to HIFb
2. Tags it for proteosome destruction

Hypoxia and the oxygen effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the difference between the oxygenated and hypoxic tumor sensitivity to radiation when irradiated by high LET vs low LET irradiation?
What is the difference between their survival curves?

A

High LET (neutrons): more direct effect (70% vs 30%), less influenced by oxygenation
Low LET (x-ray, electron, gamma): more indirect effect (70% vs 30%), more influenced by oxygenation
High LET curves are closer together. Hypoxia shows more resistance.

Hypoxia and the oxygen effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RB/CDK2-cyclinE/p21/

A

Cell cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cell cycle phases according to their radiosensitivity:

A

Mitosis: the Most sensitive
S: the most reSiStant
M>G2>earlyG1>lateG1>S

Cell cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is D0?

A

The dose required to produce on average ONE lethal lesion per irradiated cell.

Survival and dose response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

D0 formula:
e^-1=?

A

0.37

Survival and dose response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SF formula

A

SF = e^-aD

Survival and dose response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

e^-2=?

A

0.135

Survival and dose response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TCP formula

A

TCP = e ^ -x

x = number of surviving clones

Survival and dose response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the most common causes of cancer-causing mutations?

A

66% random DNA replication errors
29% environmental factors
5% inherited mutations

Radiation carcinogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which gene mutation is significantly enriched in hematopoietic cells of
patients treated with genotoxic cancer therapy?

A

P53

Radiation carcinogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the master kinase and its sensor responsible for the repair of single strand DNA breaks?

A

ATR: master kinase
RPA: sensor

DNA repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the master kinase and its sensor responsible for the repair of double strand DNA breaks?

A

ATM: kinase
Mre11: sensor

DNA repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the master kinase and its sensor responsible for the NHEJ?

A

DNA PK: kinase
Ku70: sensor

DNA repair

17
Q

What is the cell cycle stage in which homologous recombination repair is most active?

A

S/G2
HR needs the sister chromatid
Cells are most radioresistent in S/G2 because their HR is active.

DNA repair

18
Q

What are the primary radiolysis products?

A

HO* (hydroxyl radical)
e- aq
H3O
H-

Radiation interactions with matter

19
Q

What does MDM2 do?

A

MDM2 represses P53 (inactivation of a tumor suppressor)
promotes P53 ubiquitinylation

Hallmarks, Tumor Suppressors, Oncogenes, Epigenetics

20
Q

How are genes epigenetically repressed? Give an example

A

via DNA methylation of the promoters
Mismatch repair proteins such as MLH1 are a canonical example of this, and are frequently methylated in microsatellite instable tumors in, for example, colorectal cancer.

Hallmarks, Tumor Suppressors, Oncogenes, Epigenetics